文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

接受扩大野放化疗的宫颈癌女性急性血液学毒性的预测因素:已知盆腔放疗骨髓限制是否适用?

Predictors of Acute Hematologic Toxicity in Women Receiving Extended-Field Chemoradiation for Cervical Cancer: Do Known Pelvic Radiation Bone Marrow Constraints Apply?
PubMed 文献 · Adv Radiat Oncol · 2022-06-13

本研究回顾性分析了2012至2018年接受扩大野放化疗(EF-CRT)联合铂类化疗的52例宫颈癌女性,评估年龄、BMI、种族、CCI及骨髓剂量学指标与≥2级血液学毒性(HT)的关系。单因素分析显示,校正种族后V5Gy≥98%与≥2级白细胞减少(P=0.02)和≥2级HT(P=0.05)相关;V20Gy<70%与≥2级白细胞减少减少相关(单因素P=0.02,多因素P<0.05)。结论认为急性HT与骨髓低剂量照射体积大及种族相关,限制骨髓V20Gy至70%至75%以下可能有益,但其他盆腔放疗骨髓限制可能不适用于该人群。

要点

  • V5Gy≥98%与≥2级白细胞减少(P=0.02)和≥2级HT(P=0.05)相关。
  • V20Gy<70%与≥2级白细胞减少减少相关(单因素P=0.02,多因素P<0.05)。
  • 年龄、BMI、CCI与HT无关联。

核心结论

  • 接受EF-CRT患者的急性HT与骨髓大体积低剂量照射及种族相关。
  • 限制骨髓V20Gy至70%至75%以下可能有益于减少HT,但其他盆腔放疗骨髓限制可能不适用于该人群。

研究设计与样本

  • 回顾性分析2012至2018年接受EF-CRT联合铂类化疗的52例宫颈癌女性。
  • 收集年龄、BMI、种族、CCI及白细胞计数、中性粒细胞绝对值、血红蛋白、血小板最低值。
  • 骨髓指标包括V5Gy、V10Gy、V15Gy、V20Gy、V25Gy、V30Gy、V35Gy、V40Gy、V45Gy(VxGy定义为接受x Gy的骨髓体积百分比)。
  • HT定义为≥2级(Cooperative Group Common Toxicity Criteria)白细胞减少、贫血、中性粒细胞减少或血小板减少。
  • 采用χ2检验、Fisher精确检验和logistic回归进行单因素(UVA)和多因素分析(MVA),并检验既往发表的骨髓剂量学限制。

主要发现

  • 单因素分析显示HT与年龄、BMI、CCI无关联。
  • 校正种族后,V5Gy≥98%与≥2级白细胞减少(P=0.02)和≥2级HT(P=0.05)相关。
  • 多数既往描述的放疗指标在本队列中未重现,但V20Gy<70%与≥2级白细胞减少减少相关(UVA P=0.02,MVA P<0.05)。
  • 急性HT与骨髓大体积低剂量照射及种族相关。

关键数值与推荐

  • HT定义为≥2级(Cooperative Group Common Toxicity Criteria)白细胞减少、贫血、中性粒细胞减少或血小板减少。
  • VxGy定义为接受x Gy的骨髓体积百分比。
  • V5Gy≥98%与≥2级白细胞减少(P=0.02)和≥2级HT(P=0.05)相关。
  • V20Gy<70%与≥2级白细胞减少减少相关(UVA P=0.02,MVA P<0.05)。
  • 限制骨髓V20Gy至70%至75%以下可能有益于减少HT。

临床怎么用

  • 作者认为限制骨髓V20Gy至70%至75%以下可能有益于减少HT。
  • 作者认为其他盆腔放疗骨髓限制可能不适用于接受EF-CRT的宫颈癌人群。

局限性

  • 本研究为回顾性分析。
  • 样本量为52例。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Patients with cervical cancer who are at high risk for para-aortic lymphatic involvement may receive extended-field chemoradiation (EF-CRT), with inclusion of the para-aortic region. Increased radiation to bone marrow (BM) may heighten hematologic toxicity (HT) and affect timely delivery of chemoradiation. Factors associated with HT in this setting have not been well studied. METHODS AND MATERIALS: This study was a retrospective analysis of women treated with EF-CRT from 2012 to 2018 with platinum-based chemotherapy. Factors including age, body mass index (BMI), race, Charlson Comorbidity Index (CCI), and nadirs for white blood cell count, absolute neutrophil count, hemoglobin, and platelet count were collected. The BM metrics included V5Gy, V10Gy, V15Gy, V20Gy, V25Gy, V30Gy, V35Gy, V40Gy and V45Gy (VxGy was defined as the percentage of BM volume receiving x Gy). Hematologic toxicity was defined as grade ≥2 (Cooperative Group Common Toxicity Criteria) leukopenia, anemia, neutropenia, or thrombocytopenia. Univariate analysis (UVA) and multivariate analysis (MVA) were performed using the χ2 test, the Fisher exact test, and logistic regression. Previously published dosimetric BM constraints were examined as detailed in each respective study. RESULTS: Fifty-two women underwent EF-CRT with cisplatin. UVA showed no association between HT and age, BMI, or CCI. When accounting for race, V5Gy ≥98% was associated with grade ≥2 leukopenia (P = .02) and grade ≥2 HT (P = .05). Most previously described radiation metrics were not reproduced in our cohort, but a similar constraint, V20Gy <70%, was associated with reduced leukopenia of grade ≥2 on UVA (P = .02) and MVA (P < .05). CONCLUSIONS: Acute HT in patients receiving EF-CRT was associated with large volumes of low-dose radiation to the BM and was also associated with race. Restricting the BM V20Gy to less than 70% to 75% may be beneficial in reducing HT, but other pelvic radiation BM constraints may not be applicable to this population.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Hara JHL, Jutzy JMS, Arya R, et al. Predictors of Acute Hematologic Toxicity in Women Receiving Extended-Field Chemoradiation for Cervical Cancer: Do Known Pelvic Radiation Bone Marrow Constraints Apply? Adv Radiat Oncol. 2022. PMID: 36420189. doi:10.1016/j.adro.2022.100998

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。